Muneera S M Al-Saleem, Mohamed S Mohamed Ahmed, Sayed M Riyadh, Awatif H Alruwaili, Magdi E A Zaki, Sobhi M Gomha
{"title":"Synthesis, Molecular Characterization, and Antimicrobial Evaluation of Hydrazones Derived from 2-Hydrazinobenzimidazole.","authors":"Muneera S M Al-Saleem, Mohamed S Mohamed Ahmed, Sayed M Riyadh, Awatif H Alruwaili, Magdi E A Zaki, Sobhi M Gomha","doi":"10.2147/DDDT.S521541","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Hydrazones, due to the structural diversity of their nitrogen atoms, possess both electrophilic and nucleophilic properties, enabling strong hydrogen bonding interactions with enzymes and receptors. This study aimed to synthesize novel hydrazone derivatives and evaluate their antimicrobial potential.</p><p><strong>Methods: </strong>Hydrazones were synthesized via condensation of 2-hydrazinobenzimidazole with various aldehydes or ketones using citric acid as an eco-friendly catalyst. The (E)-configuration of the products was confirmed through frontier molecular orbital (FMO) calculations. Antimicrobial activities were assessed against selected Gram-positive and Gram-negative bacteria, and fungi. Molecular docking studies were conducted on the most active compounds (<b>3c</b> and <b>3o</b>) using bacterial and fungal protein targets (2IWC, 2NXW, 1EA1).</p><p><strong>Results: </strong>Compounds <b>3c</b> and <b>3o</b> showed strong antimicrobial activity. Docking studies revealed that both compounds interacted with 2IWC via one H-bond donor to THR531 (3.12 Å), mirroring ampicillin. Against 2NXW, they showed dual H-donor bonding to MET404 with binding energies of -5.96 and -5.72 kcal/mol, comparable to gentamicin. Both also bound ARG326 in 1EA1 with binding energies of -5.97 and -6.0 kcal/mol, similar to nystatin.</p><p><strong>Discussion: </strong>The comparable binding patterns and energies of compounds <b>3c</b> and <b>3o</b> to standard antimicrobial agents suggest that they are promising candidates for further development as broad-spectrum antimicrobial agents.</p>","PeriodicalId":11290,"journal":{"name":"Drug Design, Development and Therapy","volume":"19 ","pages":"4437-4456"},"PeriodicalIF":5.1000,"publicationDate":"2025-05-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12126145/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Design, Development and Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/DDDT.S521541","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: Hydrazones, due to the structural diversity of their nitrogen atoms, possess both electrophilic and nucleophilic properties, enabling strong hydrogen bonding interactions with enzymes and receptors. This study aimed to synthesize novel hydrazone derivatives and evaluate their antimicrobial potential.
Methods: Hydrazones were synthesized via condensation of 2-hydrazinobenzimidazole with various aldehydes or ketones using citric acid as an eco-friendly catalyst. The (E)-configuration of the products was confirmed through frontier molecular orbital (FMO) calculations. Antimicrobial activities were assessed against selected Gram-positive and Gram-negative bacteria, and fungi. Molecular docking studies were conducted on the most active compounds (3c and 3o) using bacterial and fungal protein targets (2IWC, 2NXW, 1EA1).
Results: Compounds 3c and 3o showed strong antimicrobial activity. Docking studies revealed that both compounds interacted with 2IWC via one H-bond donor to THR531 (3.12 Å), mirroring ampicillin. Against 2NXW, they showed dual H-donor bonding to MET404 with binding energies of -5.96 and -5.72 kcal/mol, comparable to gentamicin. Both also bound ARG326 in 1EA1 with binding energies of -5.97 and -6.0 kcal/mol, similar to nystatin.
Discussion: The comparable binding patterns and energies of compounds 3c and 3o to standard antimicrobial agents suggest that they are promising candidates for further development as broad-spectrum antimicrobial agents.
期刊介绍:
Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications.
The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas.
Specific topics covered by the journal include:
Drug target identification and validation
Phenotypic screening and target deconvolution
Biochemical analyses of drug targets and their pathways
New methods or relevant applications in molecular/drug design and computer-aided drug discovery*
Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes)
Structural or molecular biological studies elucidating molecular recognition processes
Fragment-based drug discovery
Pharmaceutical/red biotechnology
Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products**
Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development
Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing)
Preclinical development studies
Translational animal models
Mechanisms of action and signalling pathways
Toxicology
Gene therapy, cell therapy and immunotherapy
Personalized medicine and pharmacogenomics
Clinical drug evaluation
Patient safety and sustained use of medicines.